Week 352 Review - Yet another big drop

Here we go again. The deficit between cost and value widened by £4,748 to £87,069 and value dropped to £93,901. Not sure how much more of this I can stand.

Biggest loser was IGG:IG Group which dropped 10% and i have no clue why, as volatile markets are good for their profits.

CAML:Central Asia Metals dropped 6% but is still 8% up. Big dividend coming in a few weeks.

OPTI:Optibiotix dropped another 2p which is less than 5% but contributed £3,400 of the drop.

Back below the injection line

Devastating

Here's the ISA and shares portfolio after week 40 of year 7.

			Weekly Change
Cash	£10.18		-£8.12
Portfolio cost	£82,912.77		+£313.95
Portfolio sell value (bid price-commission)	£41,712.93	(-49.7%)	-£2,301.08
Potential profits	£1,420.05		-£695.24
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£305.83
Yr 7 projected avg monthly profit	£1,556.30	(42.2%)	-£5.93
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£305.83
Average monthly cash profit	£486.90	(13.2%)	+£2.39
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

I couldn't stand OPTI:Optibiotix dropping so much, so I decided to bank some profits from JLP:Jubilee Metals to get some more. I sold 6,500 shares at 15.82p and made £736.59 (252.5%) profit. I used the proceeds to buy 3,516 shares at 28.7975p costing £1,024.47. That brought my weighted average down to 58.49p and took my total holding to 182,495.

I took the opportunity to write off my holding in WRES:W Resources as I'm certain they will go bust and never trade again. That loss was £430.75, so my profit from sales is reduced to £305.

Taking the profits wasn't enough to stop the year 7 projected profit falling, as that's still affected by the big OPTI:Optibiotix share dividend. Long term performance ticks up a bit rather than the usual small drop.

Below the injection line again

Well below the trend line

The SIPP looks like this after week 336 overall and week 24 of year 7.

			Weekly Change
Cash	£111.44		-£93.71
Portfolio cost	£95,302.86		+£154.64
Portfolio sell value (bid price - commission)	£51,036.78	(-46.4%)	-£2,428.40
Potential profits	£84.64		-£139.07
Yr 7 Dividends	£10,565.04		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£358.14		+£60.92
Yr 7 projected avg monthly profit	£1,957.22	(44.2%)	-£73.62
Total Dividends	£13,769.43		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,082.77		+£60.92
Average monthly cash profit	£476.50	(10.8%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	70%		+1%

I decided to sell my iShares Physical Gold fund holding as I thought the price of gold had got ahead of itself, and I wanted to increase my holding in PBX:Probiotix Health. I only made £60.92 (9.2%) profit, but that's OK. I bought 3,596 shares at 21.97p costing £799.99. The price hasn't changed since the IPO.

Not enough profit to make any impact on long term performance though.

Below the injection line

As with the ISA, very distressing

The trading account looks like this after week 302 overall and week 42 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£770.79	(-67.5%)	-£18.79
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£14.32	(7.2%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

The usual fall but not as far as recently

This has been under the injection line for about 7 months.

Amazingly still above the trend line.

Another week of misery but at least I made some profit and bought more OPTI:Optibiotix